http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110054606-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D455-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D455-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105
filingDate 2019-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110054606-B
titleOfInvention Dihydromyricetin-berberine hydrochloride pharmaceutical co-crystal and preparation method thereof
abstract The invention discloses a dihydromyricetin-berberine hydrochloride pharmaceutical co-crystal, belonging to the technical field of pharmaceutical crystallization. The invention combines dihydromyricetin and berberine hydrochloride together through intermolecular hydrogen bonding to form the dihydromyricetin-berberine hydrochloride pharmaceutical co-crystal. The preparation method is simple and easy to implement and low in cost. The prepared dihydromyricetin-berberine hydrochloride medicine eutectic crystal has a definite structure and no hygroscopicity, the dissolution rates of dihydromyricetin and berberine hydrochloride in water are similar, the dihydromyricetin and the berberine hydrochloride can be synchronously dissolved, and the synergistic enhanced inhibition effect is shown on specific tumor cells.
priorityDate 2019-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108530440-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12306070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453357071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12456

Total number of triples: 31.